Oxford Nanopore Technologies plc

205.80pAs of Sun 8 Nov 2026, 12:00 UTC
LSE:ONTHealthcare
Ctry United Kingdom
PE (Fwd) •••
TSR 5Y CAGR (19.24%)
Div yield —
ROE (25.63%)
Biotechnology
Beta (5Y) 1.01
PE TTM —
TSR TTM 50.22%
Mkt cap £2.014B
ROIC (13.10%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
215p
4.42%
(9.64%)
Hold 11|6|7|11|9
4Q25
1Q26
2Q26
3Q26
Earnings per share£
2.44
2.52
2.44
2.55
5.29%
13.87%
1.66%
5.09%
Revenue£M
192.1
200.3
197.8
199.6
9.42%
9.30%
8.39%
3.75%
Peers (US$2.709B)
Cap (US$)
PE
2.071B
5.627x
2.700B
36.65x
Capital
TTM
5Y
10Y
Leveragex
0.890
0.330
0.348
EBIT/Intx
4.610
0.156
0.158
Own earn%
106.66
37.65
39.22
Sh yield%
15.54
28.64
30.17
Owners
Insiders/Inst%
12.35
31.85
Short interest%
3.79
SBC / revenue%
5.74
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
26–32
$1 testx
6.6
Incr. ROIC%
10